Viewing StudyNCT04697628



Ignite Creation Date: 2024-05-06 @ 3:37 PM
Last Modification Date: 2024-10-26 @ 1:53 PM
Study NCT ID: NCT04697628
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-06-18
First Post: 2021-01-04

Brief Title: Tisotumab Vedotin vs Chemotherapy in Recurrent or Metastatic Cervical Cancer
Sponsor: Seagen Inc
Organization: Seagen Inc

Organization Data

Organization: Seagen Inc
Class: INDUSTRY
Study ID: SGNTV-003
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Seagen Inc
Lead Sponsor Class: INDUSTRY
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
Genmab INDUSTRY